Students will:Analyze roles of the Drug Enforcement AdministrationAnalyze PMHNP responsibilities when issued a DEA numberAnalyze DEA number application proceduresAnalyze state requirements for safe pr

Hire our professional essay experts at Gradehunters.net who are available online 24/7 for an essay paper written to a high standard at an affordable cost.


Order a Similar Paper Order a Different Paper


Students will:

Analyze roles of the Drug Enforcement Administration

Analyze PMHNP responsibilities when issued a DEA number

Analyze DEA number application procedures

Analyze state requirements for safe prescribing and prescription monitoring

Analyze PMHNP responsibilities for safe prescribing and prescription monitoring

Analyze Schedule II-V drug levels

To prepare for this Practicum Journal: Review the Learning Resources.


In 3 pages:


Thesis statement


Describe the role of the Drug Enforcement Administration (DEA) as it pertains to the PMHNP.


Explain your responsibilities when having a DEA number.


Explain how you apply for a DEA number.


Explain your state’s requirements for a safe prescribing and prescription monitoring program.


Explain your responsibility as a PMHNP to follow these requirements.


Provide an example of a drug you may prescribe from each of the Schedule II-V drug levels.

Students will:Analyze roles of the Drug Enforcement AdministrationAnalyze PMHNP responsibilities when issued a DEA numberAnalyze DEA number application proceduresAnalyze state requirements for safe pr
Assignment 2: Week 2 Practicum Journal: Safe Prescribing Students will: Analyze roles of the Drug Enforcement Administration Analyze PMHNP responsibilities when issued a DEA number Analyze DEA number application procedures Analyze state requirements for safe prescribing and prescription monitoring Analyze PMHNP responsibilities for safe prescribing and prescription monitoring Analyze Schedule II-V drug levels To prepare for this Practicum Journal: Review the Learning Resources. In 3 pages: Describe the role of the Drug Enforcement Administration (DEA) as it pertains to the PMHNP. Explain your responsibilities when having a DEA number. Explain how you apply for a DEA number. Explain your state’s requirements for a safe prescribing and prescription monitoring program. Explain your responsibility as a PMHNP to follow these requirements. Provide an example of a drug you may prescribe from each of the Schedule II-V drug levels. Required Readings Sadock, B. J., Sadock, V. A., & Ruiz, P. (2014). Kaplan & Sadock’s synopsis of psychiatry: Behavioral sciences/clinical psychiatry (11th ed.). Philadelphia, PA: Wolters Kluwer. Chapter 8, “Mood Disorders” (pp. 347–386) Gabbard, G. O. (2014). Gabbard’s treatment of psychiatric disorders (5th ed.). Washington, DC: American Psychiatric Publications. Chapter 12, “Psychotherapy of Mood Disorders” Chapter 14, “Pharmacological and Somatic Treatments for Major Depressive Disorder” Note: You will access this textbook from the Walden Library databases. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author. “Depressive Disorders” Major Depressive Disorder Persistent Depressive Disorder (dysthymia) Premenstrual Dysphoric Disorder Substance/Medication-Induced Depressive Disorder Depressive Disorder Due to Another Medical Condition Other Specified Depressive Disorder Unspecified Depressive Disorder Stahl, S. M. (2014). Prescriber’s Guide: Stahl’s Essential Psychopharmacology (5th ed.). New York, NY: Cambridge University Press.   Note: All Stahl resources can be accessed through the Walden Library using the link below. This link will take you to a login page for the Walden Library. Once you log in to the library, the Stahl website will appear. http://ezp.waldenulibrary.org/login?url=http://stahlonline.cambridge.org/   To access information on specific medications, click on The Prescriber’s Guide, 5th Ed. tab on the Stahl Online website and select the appropriate medication. Depression Premenstrual dysphoric disorder Seasonal affective disorder (MDD with Seasonal Variation) agomelatineamisulprideamitriptylineamoxapineamphetamine (d)amphetamine (d,l)aripiprazole (adjunct)asenapineatomoxetinebupropionbuspirone (adjunct)citalopramclomipraminecyamemazinedesipraminedesvenlafaxinedothiepinparoxetinephenelzineprotriptyline quetiapine (adjunct)reboxetineselegilinesertindolesertralinesulpiridetianeptinetranylcyprominetriiodothyroninetrazodonetrimipraminevenlafaxinevilazodonevortioxetinedoxepinduloxetineescitalopramfluoxetineflupenthixolfluvoxamine iloperidoneimipramineisocarboxazidketaminelisdexamfetaminelithium (adjunct)l-methylfolate (adjunct)lofepraminelurasidonemaprotilinemethylphenidate (d)methylphenidate (d,l)mianserinmilnacipranmirtazapinemoclobemidemodafinil (adjunct)nefazodonenortriptylineolanzapine citalopramdesvenlafaxineescitalopramfluoxetineparoxetinesertralinevenlafaxine bupropion Grieve, S. M., Korgaonkar, M. S., Koslow, S. H., Gordon, E., Williams, L. M. (2013). Widespread reductions in gray matter volume in depression. NeuroImage: Clinical, 3, 332-339. doi:10.1016/j.nicl.2013.08.016 Note: You will access this article from the Walden Library databases. Lach, H. W., Chang, Y-P., & Edwards, D. (2010). Can older adults with dementia accurately report depression using brief forms? Reliability and validity of the Geriatric Depression Scale. Journal of Gerontological Nursing, 36(5), 30–37. doi:10.3928/00989134-20100303-01 Note: You will access this article from the Walden Library databases. Steffens, D. C., McQuoid, D. R., & Potter, G. G. (2014). Amnestic mild cognitive impairment and incident dementia and Alzheimer’s disease in geriatric depression. International Psychogeriatrics, 26(12), 2029–2036. doi:10.1017/S1041610214001446 Note: You will access this article from the Walden Library databases. Drug Enforcement Administration. (n.d.). Drug schedules. Retrieved June 14, 2016, from https://www.dea.gov/druginfo/ds.shtml Hagen, B. (Producer). (n.d.-b). Managing depression [Video file]. Mill Valley, CA: Psychotherapy.net.   Note: The approximate length of this media piece is 24 minutes. You will access this video through the Walden Library databases. Optional Resources Gabbard, G. O. (2014). Gabbard’s treatment of psychiatric disorders (5th ed.). Washington, DC: American Psychiatric Publications. Chapter 15, “Brain Stimulation Treatments for Mood Disorders” Note: You will access this article from the Walden Library databases. Ahern, E., & Semkovska, M. (2017). Cognitive functioning in the first-episode of major depressive disorder: A systematic review and meta-analysis. Neuropsychology, 31(1), 52–72. doi:10.1037/neu0000319 Note: You will access this article from the Walden Library databases. Anderson, N. D., Damianakis, T., Kröger, E., Wagner, L. M., Dawson, D. R., Binns, M. A., . . . Cook, S. L. (2014). The benefits associated with volunteering among seniors: A critical review and recommendations for future research. Psychological Bulletin, 140(6), 1505–1533. doi:10.1037/a0037610 Note: You will access this article from the Walden Library databases. Inoue, J., Hoshino, R., Nojima, H., Ishida, W., & Okamoto, N. (2016). Additional donepezil treatment for patients with geriatric depression who exhibit cognitive deficit during treatment for depression. Psychogeriatrics, 16(1), 54–61. doi:10.1111/psyg.12121 Note: You will access this article from the Walden Library databases. Sachs-Ericsson, N., Corsentino, E., Moxley, J., Hames, J. L., Rushing, N. C., Sawyer, K., . . . Steffens, D. C. (2013). A longitudinal study of differences in late- and early-onset geriatric depression: Depressive symptoms and psychosocial, cognitive, and neurological functioning. Aging & Mental Health, 17(1), 1–11. doi:10.1080/13607863.2012.717253 Note: You will access this article from the Walden Library databases. Shallcross, A. J., Gross, J. J., Visvanathan, P. D., Kumar, N., Palfrey, A., Ford, B. Q., . . . Mauss, I. B. (2015). Relapse prevention in major depressive disorder: Mindfulness-based cognitive therapy versus an active control condition. Journal of Consulting and Clinical Psychology, 83(5), 964–975. doi:10.1037/ccp0000050 Note: You will access this article from the Walden Library databases. Wanklyn, S. G., Pukay-Martin, N. D., Belus, J. M., St. Cyr, K., Girard, T. A., & Monson, C. M. (2016). Trauma types as differential predictors of posttraumatic stress disorder (PTSD), major depressive disorder (MDD), and their comorbidity. Canadian Journal of Behavioural Science / Revue Canadienne Des Sciences Du Comportement, 48(4), 296–305. doi:10.1037/cbs0000056 Note: You will access this article from the Walden Library databases.

Writerbay.net

Everyone needs a little help with academic work from time to time. Hire the best essay writing professionals working for us today!

Get a 15% discount for your first order


Order a Similar Paper Order a Different Paper